Sanjay Popat

37PUBLICATIONS
173CO-AUTHORS
Molecular targetsImmunology not elsewhere classifiedPredictive and prognostic markersEnvironmental and resources law not elsewhere classifiedEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Sep 09, 2026
Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial.

|Sep 02, 2026
Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature.

|May 05, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Feb 04, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial.

Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova

|Aug 21, 2025
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer.

Alind Gupta, Stephen Duffield, Cal Shephard

Pageof 7

Frequent Collaborators

6 joint publications

Charles Swanton

4 joint publications

Gary Middleton

3 joint publications

Allan Hackshaw

3 joint publications

Alexander Drilon